Abstract
Parkinson´s disease (PD) is a neurodegenerative disease, partially characterized by the loss of dopaminergic neurons in the substantia nigra and their projections to the striatum, causing a wide range of motor deficits. The most used treatment to date is the L-DOPA administration, however it has limited efficacy and diverse side effects, like diskynesias.It was recently demonstrated that …